$2.29 0.02 (+0.88%)
11/25/2009 4:00 PM

Ariad Pharmaceuticals, Inc. (ARIA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Featured Broker Partners